Australian pharma firm Genetic Signatures gains as Bell Potter lifts PT

Genetic Signatures

11/07/2024 04:08

** Shares of Australia's Genetic Signatures  GSS.AX  rise as
much as 6.2% to A$0.78, their highest since early June
    ** Analysts at Bell Potter raise PT on the pharmaceutical
company to A$1.1 from A$0.75; keep stock rating at "Buy"
    ** Brokerage says FY25 set to be positive year for the
drugmaker post appointment of "experienced" CEO 
    ** Bell Potter highlights strength of co's improved balanced
sheet post recent capital raise
    ** Stock has risen 67.8% this year as of last close

 (Reporting by Rishav Chatterjee in Bengaluru)
 ((Rishav.Chatterjee@thomsonreuters.com;))